1,1-Dioxo-isothiazolidine-3-carboxylic acid, 97.0%, 1g

4-Methoxy-2,3,5-trimethylpyride-N-oxide, 95.0%, 100mg

(R)-4-Phenyl-2-(quinolin-8-yl)-4,5-dihydrooxazole, 98%, 100mg

4-isopropyl-5-methyl-4H-1,2,4-triazole-3-thiol, 1g

Plan PLPHi S40x/0.65 phase contrast IOS infinity corrected objective

N-(2-(2-(2-Methoxy-4-MorpholinophenylaMino)-5-fluoropyriMidin-4-ylaMino)phenyl)MethanesulfonaMide, 98%, 50mg

Glass syringe with Luer Lock connection (glass, metal), 2 ml, 1 piece

Screw top bottle ROTILABO® clear glass, 10000 ml, GL 45, 1 Piece

Benzo[d]isothiazol-5-amine, 95.0%, 10g

N-([1,1'-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine, 97%, 100g

3-Azaspiro[5.5]undecane hydrochloride, 95.0%, 1g

2-[2-(Piperazin-1-yl)ethyl]-2,3-dihydro-1H-isoindole-1,3-dione dihydrochloride, 95.0%, 1g

(R)-methyl pyrrolidine-3-carboxylate hydrochloride, 95.0%, 1g